FHM LIFE Sciences Viii, L.P., 10% Owner, Director at Arcutis Biotherapeutics, Inc. (ARQT), bought 250,000 shares at $20.00 ($5.0M) on 2022-08-05, disclosed to the SEC on 2022-08-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| APTX | BUY | 2018-06-26 | $2.4M | — | Filing → |